ÃÀ¸ß÷
ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞЧÀÍ×Éѯ£¬£¬£¬£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com




1. 7ÔÂ8ÈÕ£¬£¬£¬£¬ÐÂŵÍþͨ¸æ£¬£¬£¬£¬¿Ø¹É×Ó¹«Ë¾¾ÞʯÉúÎï¿ËÈÕÊÕµ½ÃÀ¹úFDA֪ͨ£¬£¬£¬£¬É걨µÄ×¢ÉäÓÃSYS6023Ò©Æ·ÁÙ´²ÊÔÑéÉêÇëÒÑ»ñÅú×¼£¬£¬£¬£¬¿ÉÔÚÃÀ¹ú¿ªÕ¹ÁÙ´²ÊÔÑé¡£¡£¡£¡£¡£¡£SYS6023ÊÇÒ»¿îµ¥¿Ë¡¿¹ÌåÒ©ÎïżÁªÎ£¬£¬£¬Ë³Ó¦Ö¢ÎªÍíÆÚʵÌåÁö¡£¡£¡£¡£¡£¡£
2. 7ÔÂ7ÈÕÐÂÎÅ£¬£¬£¬£¬º£´´Ò©ÒµÐû²¼HP537ƬÓÃÓÚÖÎÁÆÑªÒºÏµÍ³¶ñÐÔÖ×ÁöµÄÁÙ´²1/2ÆÚÊÔÑéÉêÇë»ñµÃÃÀ¹úFDAÅú×¼¡£¡£¡£¡£¡£¡£´Ëǰ£¬£¬£¬£¬HP537ƬÖйúÁÙ´²ÊÔÑéÉêÇëÒÑÓÚ2024Äê2Ô»ñÖйúNMPAÅú×¼¡£¡£¡£¡£¡£¡£HP537ÊǺ£´´Ò©Òµ×ÔÖ÷Ñз¢µÄp300/CBPÒÖÖÆ¼ÁС·Ö×Ó¿¹Ö×ÁöÒ©Îï¡£¡£¡£¡£¡£¡£
3. 7ÔÂ8ÈÕ£¬£¬£¬£¬ÉîÐÅÉúÎïÐû²¼ÃÀ¹úFDAÊÚÓèÆäÔÚÑÐÐÂÒ©IN022ÓÐÊý¶ù¿Æ¼²²¡È϶¨£¨Rare Pediatric Disease Designation, RPDD£©¡£¡£¡£¡£¡£¡£IN022ÓÃÓÚÖÎÁÆÍ¬ÐÍë×°±ËáÄòÖ¢£¨Homocystinuria£¬£¬£¬£¬HCU£©£¬£¬£¬£¬Ò»ÖÖÑÏÖØÎ£º¦ÉúÃüµÄÒÅ´«ÐÔ´úл¼²²¡¡£¡£¡£¡£¡£¡£
4. 7ÔÂ5ÈÕ£¬£¬£¬£¬µÚÒ»Èý¹²£¨Daiichi Sankyo£©±½»ÇËáÃÀÂå¼Ó°ÍÁÖÆ¬»ñÅúÉÏÊУ¬£¬£¬£¬ÓÃÓÚÖÎÁƳÉÈËÌÇÄò²¡ÐÔÖÜΧÉñ¾²¡ÀíÐÔÌÛÍ´¡£¡£¡£¡£¡£¡£ÃÀÂå¼Ó°ÍÁÖÆ¬ÎªµÚÈý´ú¸ÆÀë×ÓͨµÀµ÷Àí¼ÁÀàÒ©Î£¬£¬£¬Æä×÷ÓÃλµãÊǸÆÀë×ÓͨµÀµÄ¦Á2¦ÄÑÇ»ù¡£¡£¡£¡£¡£¡£
1. ¿ËÈÕ£¬£¬£¬£¬Õã½ÆÕ¿µÉúÎï¼¼Êõ¹É·ÝÓÐÏÞ¹«Ë¾Íê³É1ÒÚÔªÕ½ÂÔÈÚ×Ê£¬£¬£¬£¬Í¶×Ê·½ÎªÑÒɽ¿Æ¼¼µÄÈ«×Ê×Ó¹«Ë¾Ö麣ÑҺϡ£¡£¡£¡£¡£¡£ÆÕ¿µÉúÎïÖ÷Òª´ÓÊÂÒßÃçµÄÑз¢¡¢Éú²ú¼°ÏúÊÛ£¬£¬£¬£¬Ö÷Òª²úƷΪ¶³¸É¼×Ð͸ÎÑ×¼õ¶¾»îÒßÃ磬£¬£¬£¬Í¬Ê±ÔÚÆð¾¢Ñз¢¶³¸ÉÈËÓÿñÈ®²¡ÒßÃç(È˶þ±¶Ìåϸ°û)¡¢¼×¸ÎÃð»îÒßÃ硢ϸ°û»ùÖÊÁ÷¸ÐÒßÃç¡¢ÖØ×é´ø×´ðåÕîÒßÃç¡¢ºôÎüµÀºÏ°û²¡¶¾ÒßÃçµÈ²úÆ·¡£¡£¡£¡£¡£¡£
1. 7ÔÂ5ÈÕ£¬£¬£¬£¬»ªÖпƼ¼´óѧͬ¼ÃҽѧԺÁ¥Êôͬ¼ÃÒ½Ôº¸ßÇìÀÙ½ÌÊÚ¡¢·½Ó½ÌÊÚ¡¢Âí¶¡ÔºÊ¿ÁªºÏµÂ¿ËÈøË¹´óѧ MD Anderson °©Ö¢ÖÐÐÄÁºêϽÌÊÚµÈÍŶÓÔÚ Cell ½ÒÏþÑо¿¡£¡£¡£¡£¡£¡£Í¨¹ý¶Ô 127 Àý¸ß¼¶±ð½¬ÒºÐÔÂѳ²°©£¨High-Grade Serous Ovarian Cancer£¬£¬£¬£¬HGSOC£©Ñù±¾¾ÙÐе¥Ï¸°ûºÍ¶àģ̬ÆÊÎö£¬£¬£¬£¬Ç¿µ÷ÁËÒÔЧӦÐÔ Treg ϸ°ûÎªÖØµãµÄÖÎÁÆ HGSOC ºÍÆäËû HRD Ïà¹ØÖ×Áö¼²²¡µÄDZÁ¦£¬£¬£¬£¬ÎªÁÙ´²ÉÏͨ¹ý PARP ÒÖÖÆ¼ÁÖÎÁÆÂѳ²°©Ìṩָµ¼¡£¡£¡£¡£¡£¡£
[1]Luo et al.Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors.Cell.2024
Ïà¹ØÐÂÎÅʱ¼ä£º2020Äê12ÔÂ09-10ÈÕ
ËùÔÚ£ºÉϺ£ÆÖ¶«Â̵ز¬æêÂùÝ
ʱ¼ä£º2018Äê10ÔÂ25ÈÕ 14:00-16:00
ËùÔÚ£º´óÐËÇø±±¾©ÒàׯÉúÎïÒ½Ò©Ô°¿§·ÈÌü